Viral Disease Diagnosis Market
Viral Disease Diagnosis Market Study by Direct Specimen Examination, Viral Isolation, Molecular Techniques, Microarray Technique, and Serodiagnostic Kits For Hospitals, and Others From 2024 to 2034
Analysis of Viral Disease Diagnosis Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Viral Disease Diagnosis Market Outlook (2024 to 2034)
The global viral disease diagnosis market is analyzed to reach US$ 55 billion in 2024 and is forecasted to expand at a CAGR of 9.8% to achieve a valuation of US$ 139.93 billion by 2034.
The utilization of point-of-care testing (POCT) devices for the diagnosis of infectious diseases is increasing dramatically due to the rising prevalence of chronic diseases, which is pushing people to buy viral disease diagnosis kits. Quick tests at the bedside or in remote locations are made possible by these lightweight, user-friendly gadgets, which promote quick diagnosis and treatment commencement from the comfort of home, this notable factor is making people invest in such kits.
POCT is becoming more popular, especially in places with limited resources and during outbreaks when access to centralized labs is restricted. Data analysis, interpretation, and decision-making procedures are streamlined by the incorporation of AI and machine learning algorithms into the diagnostic system.
Governments from several countries are making significant investments in disease surveillance initiatives and healthcare infrastructure. The need to prepare and respond to infectious disease outbreaks is driving an increase in funding for research & development in infectious disease diagnostics. The necessity of early identification and detection of infectious illnesses is becoming more widely recognized. Healthcare campaigns and educational initiatives that highlight the advantages of early intervention in managing and containing the development of disease serve to raise awareness of this issue.
The increasing healthcare spending in several regions is making it possible for more people to receive advanced diagnostic services and instruments. This is especially true in countries where expanding access to healthcare is a top concern, which encourages the use of infectious disease diagnostics.
| Report Attributes | Details |
|---|---|
| Viral Disease Diagnosis Market Size (2024E) | US$ 55 Billion |
| Forecasted Market Value (2034F) | US$ 139.93 Billion |
| Global Market Growth Rate (2024 to 2034) | 9.8% CAGR |
| East Asia Market Growth Rate (2024 to 2034) | 10% |
| North America Market Value (2034F) | 60.82 Billion |
| Homecare Segment Growth Rate (2024 to 2034) | 10.2% CAGR |
| Viral Isolation Segment Value (2034F) | US$ 3.08 Billion |
| Key Companies Profiled | Thermo Fisher Scientific; Adaltis S.r.l; R-Biopharm AG; Siemens Healthcare Private Limited; Toronto Bioscience; Merck KGaA; Abbott Laboratories; BioMérieux SA; Cepheid; Epitope Diagnostics Inc.; F. Hoffmann-La Roche Ltd; Elabscience Biotechnology Inc.; Mylab Discovery Solutions Pvt. Ltd.; Altona Diagnostics GmbH; TIB Molbiol; Luminex Corporation; Becton; Dickinson and Company. |
According to the research, Viral Disease Diagnosis consists of estimating a load of either antigen or antigen-specific antibodies due to immune response. The growth of diagnostics is projected due to the rise in viral infections and diseases. According to WHO, the fatality rate due to Ebola virus disease is around 50%, and annually 3-5 million cases of severe illness are caused by to influenza virus.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Demand for Viral Disease Diagnosis?
Changes in the viral genome are acting as the primary challenge for the detection of the virus, making diagnosis difficult. As a result, various new techniques, such as microarray techniques and rapid tests, are emerging. The global virological diagnosis market is driven by increasing research & development for the detection of the virus. According to WHO, globally, 1.5 million new infections are occurring per year. This increase in infection rates is directly having a positive impact on the viral diagnostic market.
The United States and Canada Viral Disease Diagnosis Market Outlook
The United States and Canada lead the viral diagnostic market because of the presence of major manufacturing companies. As compared to other developed countries, the United States spends 18% of its GDP on healthcare and the treatment of diseases in this region. Apart from this, several advancements are occurring in the technologies that are driving the market growth in this region.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Who are the Key Manufacturers and Suppliers of Viral Disease Diagnosis?
Some of the key players operating in the Viral Disease Diagnosis Market are
- Thermo Fisher Scientific
- Adaltis S.r.l
- R-Biopharm AG
- Siemens Healthcare Private Limited
- Toronto Bioscience
- Merck KGaA
- Abbott Laboratories
- BioMérieux SA
- Cepheid
- Epitope Diagnostics Inc.
- F. Hoffmann-La Roche Ltd
- Elabscience Biotechnology Inc.
- Mylab Discovery Solutions Pvt. Ltd.
- Altona Diagnostics GmbH
- TIB Molbiol
- Luminex Corporation
- Becton
- Dickinson and Company.
Viral Disease Diagnosis Market Report Highlights
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segmentation of Viral Disease Diagnosis Market Research
-
By Product Type :
- Direct Specimen Examination
- Viral Isolation
- Molecular Techniques
- Microarray Techniques
- Serodiagnostic Kits
-
By Virus :
- HIV Infection
- SARS-CoV
- Influenza Viruses
- Hepatitis C Virus
- Hepatitis B Virus
- Hepatitis A Virus
- Influenza A & Influenza B Virus
-
By End Use :
- Homecare
- Diagnostic Centers
- Nursing Homes
- Hospitals
- Clinics
- Laboratories
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction Taxonomy Market Definition
- 3. Market Trends and Success Factors Macro-economic Factors Market Dynamics Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast Historical Analysis Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Product Type
- 6.2. End-Use
- 6.3. Virus
- 7. Global Market Analysis and Forecast, By Product Type
- 7.1. Direct Specimen Examination
- 7.2. Viral Isolation
- 7.3. Molecular Techniques
- 7.4. Microarray Technique
- 7.5. Serodiagnostic Kits
- 8. Global Market Analysis and Forecast, By End-Use
- 8.1. Homecare
- 8.2. Diagnostic Centres
- 8.3. Nursing Homes
- 8.4. Hospitals
- 8.5. Clinics
- 8.6. Laboratories
- 9. Global Market Analysis and Forecast, By Virus
- 9.1. HIV Infection
- 9.2. SARS-CoV
- 9.3. Influenza Viruses
- 9.4. Hepatitis C Virus
- 9.5. Hepatitis B Virus
- 9.6. Hepatitis A Virus
- 9.7. Influenza A and Influenza B Viruses
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, By Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, By Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, By Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, By Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, By Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis and Forecast, By Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, By Key Segments and Countries
- 18. Sales Forecast By Product Type, End-Use, and Virus for 30 Countries
- 19. Competition Outlook, Market Structure Analysis, Company Share Analysis by Key Players, Competition Dashboard
- 20. Company Profile
- 20.1. Thermo Fisher Scientific
- 20.2. Adaltis S.r.l
- 20.3. R-Biopharm AG
- 20.4. Siemens Healthcare Private Limited
- 20.5. Toronto Bioscience
- 20.6. Merck KGaA
- 20.7. Abbott Laboratories
- 20.8. BioMérieux SA
- 20.9. Cepheid
- 20.10. Epitope Diagnostics Inc.
- 20.11. F. Hoffmann-La Roche Ltd
- 20.12. Elabscience Biotechnology Inc.
- 20.13. Mylab Discovery Solutions Pvt. Ltd.
- 20.14. Altona Diagnostics GmbH
- 20.15. TIB Molbiol
- 20.16. Luminex Corporation
- 20.17. Becton
- 20.18. Dickinson and Company
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Product Type
Table 3: Global Market US$ Mn Forecast by End-Use
Table 4: Global Market US$ Mn Forecast by Virus
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Product Type
Table 7: North America Market US$ Mn Forecast by End-Use
Table 8: North America Market US$ Mn Forecast by Virus
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Product Type
Table 11: Latin America Market US$ Mn Forecast by End-Use
Table 12: Latin America Market US$ Mn Forecast by Virus
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Product Type
Table 15: Western Europe Market US$ Mn Forecast by End-Use
Table 16: Western Europe Market US$ Mn Forecast by Virus
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Product Type
Table 19: Eastern Europe Market US$ Mn Forecast by End-Use
Table 20: Eastern Europe Market US$ Mn Forecast by Virus
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Product Type
Table 23: East Asia Market US$ Mn Forecast by End-Use
Table 24: East Asia Market US$ Mn Forecast by Virus
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Product Type
Table 27: South Asia & Pacific Market US$ Mn Forecast by End-Use
Table 28: South Asia & Pacific Market US$ Mn Forecast by Virus
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Product Type
Table 31: MEA Market US$ Mn Forecast by End-Use
Table 32: MEA Market US$ Mn Forecast by Virus
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End-Use
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Virus
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what rate is the market for viral disease diagnosis projected to rise?
The demand for viral disease diagnosis is projected to rise at 9.8% CAGR over the forecast years.
Why viral disease diagnosis market have high growth potential?
The rising prevalence of viral diseases is driving the viral disease diagnosis market growth.
Where are the most opportunities for viral disease diagnosis service providers?
Asia Pacific region is projected to be the key lucrative market for viral disease diagnosis service providers.
Viral Disease Diagnosis Market